Author

Petra Anna Golovics 1

1 1st Department of Medicine,SEMMELWEIS UNIVERSITY,Budapest,Hungary

ARE EXTRAINTESTINAL MANIFESTATIONS ASSOCIATED WITH DISEASE OUTCOMES IN INFLAMMATORY BOWEL DISEASES? RESULTS FROM THE VESZPREM POPULATION BASED INCEPTION COHORT DATABASE

Petra Anna Golovics, Barbara Dorottya Lovasz, Zsuzsanna Vegh, Istvan Szita, Mihaly Balogh, Stephan Vavricka, Gerhard Rogler, Peter L Lakatos, Peter L Lakatos

ARE EXTRAINTESTINAL MANIFESTATIONS ASSOCIATED WITH DISEASE OUTCOMES IN INFLAMMATORY BOWEL DISEASES? RESULTS FROM THE VESZPREM POPULATION BASED INCEPTION COHORT DATABASE

Petra Anna Golovics

BIOSIMILAR INFLIXIMAB: EFFICACY AND SAFETY BASED ON INTERIM RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Klaudia Farkas, Barbara Dorottya Lovasz, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Tünde Kristóf, Peter L Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamás Szamosi, Zoltan Gabor Szepes, Gábor Tamás Tóth, Aron Vincze;;

CHANGES IN THERAPEUTIC STRATEGY AND OUTCOMES IN NEWLY DIAGNOSED PATIENT WITH CROHN’S DISEASE IN THE BIOLOGICAL ERA IN HUNGARY: A NATIONWIDE STUDY BASED ON THE NATIONAL HEALTH INSURANCE FUND DATABASE

Zsuzsanna Kürti, Lorant Gonczi, Zsuzsanna Vegh, Petra Anna Golovics, Petra Fadgyas-Freyler, Judit Gimesi-Országh, Gyula Korponai, Barbara Dorottya Lovasz, Krisztina Barbara Gecse, Peter L Lakatos

CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY

Lorant Gonczi, Kata Szántó, Klaudia Farkas, Tamás Molnár, Tamás Szamosi, Eszter Schäfer, Petra Anna Golovics, Barbara Dorottya Lovasz, Mark Juhasz, Árpád V. Patai, Aron Vincze, Patrícia Sarlós, Karoly Palatka, Alexandra Farkas, Gábor Tamás Tóth, Peter L Lakatos, Pal Miheller, Ákos Iliás

COST-UTILITY OF BIOSIMILAR INFLIXIMAB (INFLECTRA©) FOR THE TREATMENT OF LUMINAL CROHN?S DISEASE IN NINE EUROPEAN COUNTRIES

Fanni Rencz, Valentin Brodszky, Petra Baji, Marta Pentek, Laszlo Gulacsi, Petra Anna Golovics, Zsuzsanna Vegh, Krisztina Barbara Gecse, Silvio Danese, Peter Irving, Peter L Lakatos

COST-UTILITY OF BIOSIMILAR INFLIXIMAB FOR THE TREATMENT OF FISTULISING CROHN?S DISEASE IN NINE EUROPEAN COUNTRIES

Petra Baji, Marta Pentek, Valentin Brodszky, Laszlo Gulacsi, Fanni Rencz, Petra Anna Golovics, Krisztina Barbara Gecse, Zsuzsanna Vegh, Silvio Danese, Peter Irving, Peter L Lakatos

EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Barbara Dorottya Lovasz, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Lilla Laura Lakner, Árpád V. Patai, Ágnes Szabone Salamon;;

EFFICACY OF INFLIXIMAB BIOSIMILAR CT-P13 INDUCTION THERAPY ON MUCOSAL HEALING IN ULCERATIVE COLITIS

Tamás Molnár, Renáta Bor, Mariann Rutka, Petra Anna Golovics, Zsuzsanna Vegh, Barbara Dorottya Lovasz, Tibor Nyári, Krisztina Barbara Gecse, Martin Kolar, Martin Bortlík, Dana Duricova, Nadezda Machkova, Veronica Hruba, Martin Lukas, Katarina Mitrova, Karin Malíčková, Anita Balint, Ferenc Nagy, Renáta Bor, Ágnes Milassin

EFFICACY OF THE NEW INFLIXIMAB BIOSIMILAR CT-P13 INDUCTION THERAPY ON MUCOSAL HEALING IN ULCERATIVE COLITIS PATIENTS

Tamás Molnár, Klaudia Farkas, Mariann Rutka, Petra Anna Golovics, Peter L Lakatos, Karoly Palatka, Tibor Nyári, Krisztina Barbara Gecse, Anita Balint, Ferenc Nagy, Renáta Bor, Ágnes Milassin, Zoltan Gabor Szepes

Item 1 - 10 / 36
1
2 3 4